Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2018 | Accelerating clinical trials in transplantation

Charles Craddock • 12 Oct 2018
BOPA 2018

Charles Craddock, CBE, FRCP(UK), FRCPath, DPhil, of the University of Birmingham, Birmingham, UK, talks about the collective organizational efforts to improve stem cell transplant therapies for the treatment of hematological cancers through a trials acceleration model. Prof. Craddock outlines prospective trials, including a randomized donor leukocyte infusion (DLI) trial in patients who have undergone transplant, allogeneic/ autologous stem cell transplant trials, and trials looking into optimizing supportive patient care. This interview was recorded at the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, held in Birmingham, UK.

More from Charles Craddock

2:14
Addressing the high rate of disease relapse following alloSCT in patients with AML
Charles Craddock • 10 Dec 2023
1:32
Stem cell transplantation conditioning in AML: making the decision between MAC and RIC
Charles Craddock • 10 Dec 2023
1:22
The UK Impact Transplant Trials Network: a national strategy to accelerate delivery of alloSCT RCTs
Charles Craddock • 10 Dec 2023
Transplantation & immunotherapies
Charles Craddock et al. • 4 Sep 2023
The content of VJHemOnc is intended for healthcare professionals